BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 26276145)

  • 21. High HER-2 protein levels correlate with clinicopathological features in colorectal cancer.
    Sun SJ; Lin Q; Sun Q; Li J; Zhang XY; Tan ZG; Song Y; Guo YT; Li Y
    J Cancer Res Ther; 2016; 12(1):323-33. PubMed ID: 27072259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic role and clinicopathological features of SMAD4 gene mutation in colorectal cancer: a systematic review and meta-analysis.
    Fang T; Liang T; Wang Y; Wu H; Liu S; Xie L; Liang J; Wang C; Tan Y
    BMC Gastroenterol; 2021 Jul; 21(1):297. PubMed ID: 34301194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic and clinicopathological value of MUC1 expression in colorectal cancer: A meta-analysis.
    Li C; Liu T; Yin L; Zuo D; Lin Y; Wang L
    Medicine (Baltimore); 2019 Mar; 98(9):e14659. PubMed ID: 30817589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The prognostic value of survivin expression in patients with colorectal carcinoma: a meta-analysis.
    Huang YJ; Qi WX; He AN; Sun YJ; Shen Z; Yao Y
    Jpn J Clin Oncol; 2013 Oct; 43(10):988-95. PubMed ID: 23894202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD44v6 overexpression related to metastasis and poor prognosis of colorectal cancer: A meta-analysis.
    Wang JL; Su WY; Lin YW; Xiong H; Chen YX; Xu J; Fang JY
    Oncotarget; 2017 Feb; 8(8):12866-12876. PubMed ID: 28030817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The clinicopathological and prognostic value of programmed death-ligand 1 in colorectal cancer: a meta-analysis.
    Ni X; Sun X; Wang D; Chen Y; Zhang Y; Li W; Wang L; Suo J
    Clin Transl Oncol; 2019 May; 21(5):674-686. PubMed ID: 30392153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicopathological and prognostic significance of survivin expression in patients with oral squamous cell carcinoma: evidence from a meta-analysis.
    Xie S; Xu H; Shan X; Liu B; Wang K; Cai Z
    PLoS One; 2015; 10(2):e0116517. PubMed ID: 25710884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HER3 protein expression in relation to HER2 positivity in patients with primary colorectal cancer: clinical relevance and prognostic value.
    Seo AN; Kwak Y; Kim WH; Kim DW; Kang SB; Choe G; Lee HS
    Virchows Arch; 2015 Jun; 466(6):645-54. PubMed ID: 25739551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High expression of anti-apoptotic protein Bcl-2 is a good prognostic factor in colorectal cancer: Result of a meta-analysis.
    Huang Q; Li S; Cheng P; Deng M; He X; Wang Z; Yang CH; Zhao XY; Huang J
    World J Gastroenterol; 2017 Jul; 23(27):5018-5033. PubMed ID: 28785155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lgr5 expression is a valuable prognostic factor for colorectal cancer: evidence from a meta-analysis.
    Jiang Y; Li W; He X; Zhang H; Jiang F; Chen Z
    BMC Cancer; 2016 Jan; 16():12. PubMed ID: 26758198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High Vimentin Expression Predicts a Poor Prognosis and Progression in Colorectal Cancer: A Study with Meta-Analysis and TCGA Database.
    Du L; Li J; Lei L; He H; Chen E; Dong J; Yang J
    Biomed Res Int; 2018; 2018():6387810. PubMed ID: 29955607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prognostic value of HER-2/neu overexpression in colorectal cancer: evidence from 16 studies.
    Wu SW; Ma CC; Yang Y
    Tumour Biol; 2014 Nov; 35(11):10799-804. PubMed ID: 25077923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is overexpression of HER-2 a predictor of prognosis in colorectal cancer?
    Kavanagh DO; Chambers G; O'Grady L; Barry KM; Waldron RP; Bennani F; Eustace PW; Tobbia I
    BMC Cancer; 2009 Jan; 9():1. PubMed ID: 19118499
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long non-coding RNA NEAT1 overexpression is associated with poor prognosis in cancer patients: a systematic review and meta-analysis.
    Yang C; Li Z; Li Y; Xu R; Wang Y; Tian Y; Chen W
    Oncotarget; 2017 Jan; 8(2):2672-2680. PubMed ID: 27926523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Downregulated E-cadherin expression indicates worse prognosis in Asian patients with colorectal cancer: evidence from meta-analysis.
    He X; Chen Z; Jia M; Zhao X
    PLoS One; 2013; 8(7):e70858. PubMed ID: 23923027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinicopathological significance and prognostic value of EphA3 and CD133 expression in colorectal carcinoma.
    Xi HQ; Zhao P
    J Clin Pathol; 2011 Jun; 64(6):498-503. PubMed ID: 21415057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Relationship between Telomerase Activity and Clinicopathological Parameters in Colorectal Cancer: A Meta-Analysis.
    Xie XC; Ge LY; Lai H; Qiu H; Tang F; Qin YZ
    Balkan Med J; 2016 Jan; 33(1):64-71. PubMed ID: 26966620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HER-2 overexpression and survival in colorectal cancer: a meta-analysis.
    Li C; Liu DR; Ye LY; Huang LN; Jaiswal S; Li XW; Wang HH; Chen L
    J Zhejiang Univ Sci B; 2014 Jun; 15(6):582-9. PubMed ID: 24903996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. β-catenin overexpression in the nucleus predicts progress disease and unfavourable survival in colorectal cancer: a meta-analysis.
    Chen Z; He X; Jia M; Liu Y; Qu D; Wu D; Wu P; Ni C; Zhang Z; Ye J; Xu J; Huang J
    PLoS One; 2013; 8(5):e63854. PubMed ID: 23717499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nuclear Notch3 expression is associated with tumor recurrence in patients with stage II and III colorectal cancer.
    Ozawa T; Kazama S; Akiyoshi T; Murono K; Yoneyama S; Tanaka T; Tanaka J; Kiyomatsu T; Kawai K; Nozawa H; Kanazawa T; Yamaguchi H; Ishihara S; Sunami E; Kitayama J; Morikawa T; Fukayama M; Watanabe T
    Ann Surg Oncol; 2014 Aug; 21(8):2650-8. PubMed ID: 24728738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.